Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus

Accumulating evidence indicates a critical role for T cells and relevant cytokines in the pathogenesis of systemic lupus erythematosus (SLE). However, the specific contribution of T cells together with the related circulating cytokines in disease pathogenesis and organ involvement is still not clear...

Full description

Saved in:
Bibliographic Details
Main Authors: Haiyan Zhou, Bojiang Li, Jing Li, Tongqian Wu, Xiaoqian Jin, Rui Yuan, Ping Shi, Yan Zhou, Long Li, Fang Yu
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2019/8450947
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559794600280064
author Haiyan Zhou
Bojiang Li
Jing Li
Tongqian Wu
Xiaoqian Jin
Rui Yuan
Ping Shi
Yan Zhou
Long Li
Fang Yu
author_facet Haiyan Zhou
Bojiang Li
Jing Li
Tongqian Wu
Xiaoqian Jin
Rui Yuan
Ping Shi
Yan Zhou
Long Li
Fang Yu
author_sort Haiyan Zhou
collection DOAJ
description Accumulating evidence indicates a critical role for T cells and relevant cytokines in the pathogenesis of systemic lupus erythematosus (SLE). However, the specific contribution of T cells together with the related circulating cytokines in disease pathogenesis and organ involvement is still not clear. In the current study, we investigated relevant molecule expressions and cytokine levels in blood samples from 49 SLE patients and 22 healthy control subjects. The expression of HLA-DR and costimulatory molecules on T cells was evaluated by flow cytometry. Concentrations of serum C-reactive protein, erythrocyte sedimentation rate, anti-double-stranded DNA (anti-dsDNA) antibody, total lgG, complement 3, and complement 4 were measured. Serum cytokines and chemokines were measured by a cytometric bead array assay. Elevated frequencies of HLA-DR+ T cells and ICOS+ T cells were observed in SLE patients with positive anti-dsDNA antibodies compared with those in healthy controls (P<0.001). The expression of HLA-DR+ T cells was positively correlated with SLEDAI (r=0.15, P<0.01). Furthermore, levels of serum IL-6, MCP-1, TNFRI, IL-10, IL-12, and CCL20 were higher in SLE patients compared with healthy controls. In addition, patients with hematologic manifestations displayed elevated frequencies of HLA-DR+ T cells and ICOS+ T cells. Patients with renal manifestations had a decreased frequency of TIGIT+ T cells. These results suggested a dysregulated T cell activity and cytokine expression profiles in SLE subjects. We also developed a chemokine and cytokine profiling strategy to predict the activity of SLE, which has clinical implication for better monitoring the flares and remission during the course of SLE and for assessing therapeutic interventions.
format Article
id doaj-art-d6dbcea076074ab9b8892620f3354fa1
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-d6dbcea076074ab9b8892620f3354fa12025-02-03T01:29:16ZengWileyMediators of Inflammation0962-93511466-18612019-01-01201910.1155/2019/84509478450947Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus ErythematosusHaiyan Zhou0Bojiang Li1Jing Li2Tongqian Wu3Xiaoqian Jin4Rui Yuan5Ping Shi6Yan Zhou7Long Li8Fang Yu9Clinical Research Center, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, ChinaDepartment of Immunology and Rheumatology, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, ChinaClinical Laboratory Center, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, ChinaClinical Research Center, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, ChinaGuizhou Medical University, Guiyang 550004, ChinaClinical Laboratory Center, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, ChinaClinical Laboratory Center, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, ChinaClinical Laboratory Center, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, ChinaDepartment of Immunology and Rheumatology, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, ChinaClinical Research Center, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, ChinaAccumulating evidence indicates a critical role for T cells and relevant cytokines in the pathogenesis of systemic lupus erythematosus (SLE). However, the specific contribution of T cells together with the related circulating cytokines in disease pathogenesis and organ involvement is still not clear. In the current study, we investigated relevant molecule expressions and cytokine levels in blood samples from 49 SLE patients and 22 healthy control subjects. The expression of HLA-DR and costimulatory molecules on T cells was evaluated by flow cytometry. Concentrations of serum C-reactive protein, erythrocyte sedimentation rate, anti-double-stranded DNA (anti-dsDNA) antibody, total lgG, complement 3, and complement 4 were measured. Serum cytokines and chemokines were measured by a cytometric bead array assay. Elevated frequencies of HLA-DR+ T cells and ICOS+ T cells were observed in SLE patients with positive anti-dsDNA antibodies compared with those in healthy controls (P<0.001). The expression of HLA-DR+ T cells was positively correlated with SLEDAI (r=0.15, P<0.01). Furthermore, levels of serum IL-6, MCP-1, TNFRI, IL-10, IL-12, and CCL20 were higher in SLE patients compared with healthy controls. In addition, patients with hematologic manifestations displayed elevated frequencies of HLA-DR+ T cells and ICOS+ T cells. Patients with renal manifestations had a decreased frequency of TIGIT+ T cells. These results suggested a dysregulated T cell activity and cytokine expression profiles in SLE subjects. We also developed a chemokine and cytokine profiling strategy to predict the activity of SLE, which has clinical implication for better monitoring the flares and remission during the course of SLE and for assessing therapeutic interventions.http://dx.doi.org/10.1155/2019/8450947
spellingShingle Haiyan Zhou
Bojiang Li
Jing Li
Tongqian Wu
Xiaoqian Jin
Rui Yuan
Ping Shi
Yan Zhou
Long Li
Fang Yu
Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus
Mediators of Inflammation
title Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus
title_full Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus
title_fullStr Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus
title_full_unstemmed Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus
title_short Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus
title_sort dysregulated t cell activation and aberrant cytokine expression profile in systemic lupus erythematosus
url http://dx.doi.org/10.1155/2019/8450947
work_keys_str_mv AT haiyanzhou dysregulatedtcellactivationandaberrantcytokineexpressionprofileinsystemiclupuserythematosus
AT bojiangli dysregulatedtcellactivationandaberrantcytokineexpressionprofileinsystemiclupuserythematosus
AT jingli dysregulatedtcellactivationandaberrantcytokineexpressionprofileinsystemiclupuserythematosus
AT tongqianwu dysregulatedtcellactivationandaberrantcytokineexpressionprofileinsystemiclupuserythematosus
AT xiaoqianjin dysregulatedtcellactivationandaberrantcytokineexpressionprofileinsystemiclupuserythematosus
AT ruiyuan dysregulatedtcellactivationandaberrantcytokineexpressionprofileinsystemiclupuserythematosus
AT pingshi dysregulatedtcellactivationandaberrantcytokineexpressionprofileinsystemiclupuserythematosus
AT yanzhou dysregulatedtcellactivationandaberrantcytokineexpressionprofileinsystemiclupuserythematosus
AT longli dysregulatedtcellactivationandaberrantcytokineexpressionprofileinsystemiclupuserythematosus
AT fangyu dysregulatedtcellactivationandaberrantcytokineexpressionprofileinsystemiclupuserythematosus